Market Overview:
The global transcervical female sterilization market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of unintended pregnancies, rising demand for permanent contraception methods, and technological advancements in transcervical female sterilization devices. Based on type, the global transcervical female sterilization market is segmented into tubal ligation and transcervical implant. Tubal ligation accounted for the majority share of the global market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to its low cost and high efficacy as compared to other contraceptive methods. Based on application, the global transcervical female sterilization market is segmented into hospital and clinic settings.
Product Definition:
A surgical procedure that blocks the fallopian tubes. It is a permanent form of birth control.
Tubal Ligation:
Tubal ligation is a surgical procedure wherein the woman's fallopian tubes are physically blocked or ligated.
1) Laparoscopic (keyhole) method - In this method, the doctor uses small incisions near the navel and inserts a laparoscope to view and operate on the reproductive organs.
Transcervical Implant:
Transcervical implant is a procedure to place a device in the uterus (womb) for sterilization. It's used in female sterilization and also for treating abnormal uterine bleeding. This surgical procedure is done by gynecologists or general surgeons with the help of laparoscope (a kind of microscope).
The transcervical implant consists of two parts: titanium coil and saran polyester film which are inserted through the cervix into the uterus.
Application Insights:
Based on application, the global transcervical female sterilization market is segmented into hospital and clinic. The hospital segment dominated the market in 2017 due to a large number of procedures being performed there compared to clinics. In addition, factors such as availability of top-quality healthcare facilities and skilled medical staff at major hospitals are also contributing towards higher usage rates in hospitals than clinics.
The clinic application segment is expected to grow at a faster rate during the forecast period owing to an increase in adoption of female sterilization procedures by gynecologists who perform these surgeries daily basis at their private practices or centers. Furthermore, growing awareness about this procedure among women as well as health care providers will also boost growth over the forecast period.
Regional Analysis:
North America dominated the global transcervical female sterilization market in 2016. This can be attributed to high incidence of infertility, rising adoption of laparoscopic surgeries, and increasing government initiatives for women's health. For instance, in 2014 U.S., around 6 million women between the age group 25-34 years were suffering from infertility problem which is about 12% population within this age group In addition, according to National Institute of Health (NIH), over 2 million women between 15-44 years suffer from Tubal Ligation Sterilization (TLS) each year which accounts for almost 1 out of 5 tubal ligations performed annually in U.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to rise in awareness regarding various methods of contraception and rising number of government campaigns on family planning aimed at reducing maternal mortality rate along with other objectives such as reduction in population growth rate.
Growth Factors:
- Increasing awareness about female sterilization as a permanent birth control method.
- Growing number of women who are choosing to delay childbearing or have fewer children.
- Rise in the number of working women and their desire for contraception that is convenient and does not require taking time off from work for appointments.
- Increased availability of transvaginal sterilization procedures through outpatient clinics and ambulatory surgery centers, which has made the procedure more accessible to a wider population of women, including those who may be reluctant to undergo traditional abdominal surgery procedures. 5) The increasing prevalence of sexually transmitted infections (STIs), which has led some women to seek out sterilization as a way to reduce their risk of contracting an STI
Scope Of The Report
Report Attributes
Report Details
Report Title
Transcervical Female Sterilization Market Research Report
By Type
Tubal Ligation, Transcervical Implant
By Application
Hospital, Clinic
By Companies
Ethicon, Medtronic, Karl Storz, Olympus, Applied Medical, Richard Wolf, Bayer AG, Stryker, B. Braun Aesculap, ERBE, LiNA Medical, ConMed, Microline Surgical, Apollo Endosurgery
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
220
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Transcervical Female Sterilization Market Report Segments:
The global Transcervical Female Sterilization market is segmented on the basis of:
Types
Tubal Ligation, Transcervical Implant
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ethicon
- Medtronic
- Karl Storz
- Olympus
- Applied Medical
- Richard Wolf
- Bayer AG
- Stryker
- B. Braun Aesculap
- ERBE
- LiNA Medical
- ConMed
- Microline Surgical
- Apollo Endosurgery
Highlights of The Transcervical Female Sterilization Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tubal Ligation
- Transcervical Implant
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transcervical Female Sterilization Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Transcervical female sterilization is a surgical procedure in which the fallopian tubes are sealed off, preventing eggs from being fertilized and resulting in permanent contraception.
Some of the major players in the transcervical female sterilization market are Ethicon, Medtronic, Karl Storz, Olympus, Applied Medical, Richard Wolf, Bayer AG, Stryker, B. Braun Aesculap, ERBE, LiNA Medical, ConMed, Microline Surgical, Apollo Endosurgery.
The transcervical female sterilization market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Transcervical Female Sterilization Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Transcervical Female Sterilization Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Transcervical Female Sterilization Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Transcervical Female Sterilization Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Transcervical Female Sterilization Market Size & Forecast, 2020-2028 4.5.1 Transcervical Female Sterilization Market Size and Y-o-Y Growth 4.5.2 Transcervical Female Sterilization Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Tubal Ligation
5.2.2 Transcervical Implant
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Transcervical Female Sterilization Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Transcervical Female Sterilization Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Tubal Ligation
9.6.2 Transcervical Implant
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Tubal Ligation
10.6.2 Transcervical Implant
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Tubal Ligation
11.6.2 Transcervical Implant
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Tubal Ligation
12.6.2 Transcervical Implant
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Tubal Ligation
13.6.2 Transcervical Implant
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Transcervical Female Sterilization Market: Competitive Dashboard
14.2 Global Transcervical Female Sterilization Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ethicon
14.3.2 Medtronic
14.3.3 Karl Storz
14.3.4 Olympus
14.3.5 Applied Medical
14.3.6 Richard Wolf
14.3.7 Bayer AG
14.3.8 Stryker
14.3.9 B. Braun Aesculap
14.3.10 ERBE
14.3.11 LiNA Medical
14.3.12 ConMed
14.3.13 Microline Surgical
14.3.14 Apollo Endosurgery